Literature DB >> 4027879

Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia.

L Deligdisch, C J Cohen.   

Abstract

The association of endometrial carcinoma (EC) with endocrinopathies manifested by obesity, nulliparity, and/or increased estrogen levels of exogenous or endogenous estrogens is now well-known. EC is also seen in patients without these findings. Are these different cancers? Seventy-four cases of EC were reviewed and classified into two groups: group I, with associated adenomatous hyperplasia (AH), 31 cases; and group II, without associated AH, 43 cases. Group I included more well-differentiated and less invasive carcinomas; histologically, the pattern was glandular in all cases. In Group II, the EC were less well-differentiated, more invasive, and included, besides adenocarcinomas, clear-cell, papillary, and anaplastic carcinomas with giant tumor cells. Squamoid features were found in both groups. The possible existence of two types of EC, a hormonal-dependent EC associated with AH (which is believed to result from hyperestrogenism, and to have a better clinical prognosis), and an "independent" EC, not associated with AH, is discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4027879     DOI: 10.1002/1097-0142(19850915)56:6<1452::aid-cncr2820560637>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Establishment and characterization of a human cell line derived from a uterine papillary serous carcinoma with wild-type p53 function.

Authors:  Hisashi Hashimoto; Atsumi Kojima; Tamotsu Sudo; Noriyoshi Ohki; Satoshi Yamaguchi; Yoshiki Mikami; Masaharu Ito; Ryuichiro Nishimura
Journal:  Hum Cell       Date:  2008-08       Impact factor: 4.174

Review 2.  Pathophysiology and management of endometrial hyperplasia and carcinoma.

Authors:  Y S Fu; J C Gambone; J S Berek
Journal:  West J Med       Date:  1990-07

3.  Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium.

Authors:  E Jason Gates; Lawrence Hirschfield; Roland P Matthews; O W Stephanie Yap
Journal:  J Natl Med Assoc       Date:  2006-11       Impact factor: 1.798

4.  Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.

Authors:  Eliana Bignotti; Antonella Ravaggi; Chiara Romani; Marcella Falchetti; Silvia Lonardi; Fabio Facchetti; Sergio Pecorelli; Joyce Varughese; Emiliano Cocco; Stefania Bellone; Peter E Schwartz; Thomas J Rutherford; Alessandro D Santin
Journal:  Int J Gynecol Cancer       Date:  2011-12       Impact factor: 3.437

5.  Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status.

Authors:  M Koshiyama; I Konishi; D P Wang; M Mandai; T Komatsu; S Yamamoto; K Nanbu; M F Naito; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 6.  The endometrial hyperplasias revisited.

Authors:  Efthimios Sivridis; Alexandra Giatromanolaki
Journal:  Virchows Arch       Date:  2008-08-23       Impact factor: 4.064

7.  beta- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis.

Authors:  M Saegusa; M Hashimura; T Yoshida; I Okayasu
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

Review 8.  Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancer.

Authors:  Kouji Banno; Yuya Nogami; Iori Kisu; Megumi Yanokura; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Wataru Yamagami; Nobuyuki Susumu; Daisuke Aoki
Journal:  Int J Mol Sci       Date:  2013-06-06       Impact factor: 5.923

9.  Small endometrial carcinoma 10 mm or less in diameter: clinicopathologic and histogenetic study of 131 cases for early detection and treatment.

Authors:  Katsuhiko Hasumi; Yuko Sugiyama; Kimihiko Sakamoto; Futoshi Akiyama
Journal:  Cancer Med       Date:  2013-09-30       Impact factor: 4.452

10.  Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.

Authors:  M Saegusa; I Okayasu
Journal:  Jpn J Cancer Res       Date:  2000-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.